Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Temozolomide for malignant brain tumours.

× No keyword cloud information.

6 in total

1. Efficacy, safety, and cost of new anticancer drugs.

Authors: Silvio Garattini; Vittorio Bertele
Journal: BMJ Date: 2002-08-03

2. Senescence Is the Main Trait Induced by Temozolomide in Glioblastoma Cells.

Authors: Lea Beltzig; Christian Schwarzenbach; Petra Leukel; Katrin B M Frauenknecht; Clemens Sommer; Alessandro Tancredi; Monika E Hegi; Markus Christmann; Bernd Kaina
Journal: Cancers (Basel) Date: 2022-04-29 Impact factor: 6.575

3. Craniospinal irradiation with concomitant and adjuvant temozolomide--a feasibility assessment of toxicity in patients with glioblastoma with a PNET component.

Authors: Ben O'Leary; Henry C Mandeville; Naomi Fersht; Francesca Solda; Julie Mycroft; Stergios Zacharoulis; Sucheta Vaidya; Frank Saran
Journal: J Neurooncol Date: 2016-02-02 Impact factor: 4.130

4. SH2B3, Transcribed by STAT1, Promotes Glioblastoma Progression Through Transducing IL-6/gp130 Signaling to Activate STAT3 Signaling.

Authors: Shan Cai; Jian-Xiang Lu; Yan-Pei Wang; Chao-Jia Shi; Tian Yuan; Xiang-Peng Wang
Journal: Front Cell Dev Biol Date: 2021-04-13

Review 5. The Roles Played by Long Non-Coding RNAs in Glioma Resistance.

Authors: Yeonsoo Chae; Jungwook Roh; Wanyeon Kim
Journal: Int J Mol Sci Date: 2021-06-25 Impact factor: 5.923

6. Accumulation of Temozolomide-Induced Apoptosis, Senescence and DNA Damage by Metronomic Dose Schedule: A Proof-of-Principle Study with Glioblastoma Cells.

Authors: Lea Beltzig; Björn Stratenwerth; Bernd Kaina
Journal: Cancers (Basel) Date: 2021-12-14 Impact factor: 6.639

6 in total